Results per Page:
When on-target misses the mark: Lessons from HIV immunogens
From the McGuire Lab, Vaccine and Infectious Disease Division
Brain trust: HCMV hijacks host chromatin to induce dormant neuronal genes
From the Avgousti Lab, Human Biology Division
House of cards: therapeutic vulnerabilities in the tumor microenvironment
From the Gujral Lab, Human Biology Division
Insights on the exapted inserted domain in integrin
From the Campbell and Malik Labs, Basic Sciences Division
X-scape artistry: CTCF insulates X-linked genes from silencing
From the Disteche Lab, University of Washington Department of Laboratory Medicine & Pathology and the Cancer Consortium program in Cancer Basic Biology
E6 oncoprotein as a biomarker used to triage anal cancer screening
From Faiza Faria, Clinical Research Division in collaboration with the University of Washington School of Public Health Department of Epidemiology
Novel drug regimen reduces risks of graft-versus-host disease
From the Hill Group, Translational Science and Therapeutics Division in collaboration with Alfred Health and Monash University
RR tracks: a new way to measure viral transmission
From the Bedford Lab, Vaccine and Infectious Disease, Public Health and Human Biology Divisions
At the intersection of Mpox and HIV infection: there is hope
From the HIV Outcomes, Prevention, and Epidemiology (HOPE) Group, Vaccine and Infectious Disease Division in collaboration with the Center for AIDS Research Network of Integrated Clinic Systems (CFAR CNICS)
Dysregulated and dysfunctional: T cell immunity in BV
From the Lund Lab, Vaccine and Infectious Disease Division
La hipertranscripción predice los resultados del cáncer gracias al Pol II
Del Laboratorio Henikoff, División de Ciencias Básicas
Targeting the Integrator complex improves reactivation of HIV
From the Emerman Lab, Human Biology Division
Oxygen toxicity in worms: a chilling tale
From the Roth Lab, Basic Sciences Division
Up in the Pol(II)s: hypertranscription predicts cancer outcomes
From the Henikoff Lab, Basic Sciences Division
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
TEC specs: tumor endothelial cells in renal cell carcinoma
From the Akilesh Lab, UW Department of Laboratory Medicine & Pathology in collaboration with the Warren Lab, Translational Science and Therapeutics and Dr. Scott Tykodi, a clinical specialist for kidney cancer in the Clinical Research Division
Decisions, decisions: factors that impact HCT outcomes in AML
From the Walter Group, Translational Sciences and Therapeutics Division
Revaccination beliefs and behaviors in transplant survivors
From the UW School of Nursing in collaboration with the Long-Term Follow-Up Program, Clinical Research Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division